Literature DB >> 28360592

The Effect of Sertraline on the Quality of Life for Children and Adolescents with Anxiety Disorder.

Nursu Çakin Memik1, Işık Karakaya1, Özlem Yildiz1, Şahika Şişmanlar1, Çiğdem Çağlayan2, Belma Ağaoğlu1.   

Abstract

INTRODUCTION: In this study, we aimed to determine the changes in quality of life of children/adolescents with anxiety disorders during six months of sertraline treatment, to investigate parent-child/adolescent concordance in perception of quality of life and to examine the effect of treatment on children/adolescents.
METHODS: In this study, 30 patients with anxiety disorders according to criteria specified in Diagnostic and Statistical Manual of Mental Disorders, 4th. Edition (DSM-IV) were assigned to sertraline treatment. The patients were evaluated using the Pediatric Quality of Life Inventory (PedsQL), State-Trait Anxiety Inventory for Children, Clinical Global Impression Scale (CGI) and the Children's Global Assessment Scale (CGAS) at 0th, 2nd and 6th months.
RESULTS: PedsQL total scores increased significantly with the treatment in children and adolescents (p<.001), however, no differences were observed in parent proxy report (p=.326). The mean CGAS score was 59.85±7.73 at the beginning of treatment and 73.70±7.01 at the end of treatment (p<.001). The average CGI score decreased from 4.68±.96 to 2.27±.84.
CONCLUSION: It was observed that perception of quality of life in children and adolescents with anxiety disorders increased with the treatment.

Entities:  

Keywords:  Anxiety disorders; adolescents; child; quality of life

Year:  2014        PMID: 28360592      PMCID: PMC5370260          DOI: 10.4274/npa.y6565

Source DB:  PubMed          Journal:  Noro Psikiyatr Ars        ISSN: 1300-0667            Impact factor:   1.339


  71 in total

1.  The prevalence of DSM-III-R diagnoses in a national sample of Dutch adolescents.

Authors:  F C Verhulst; J van der Ende; R F Ferdinand; M C Kasius
Journal:  Arch Gen Psychiatry       Date:  1997-04

2.  Retrospective assessment of prepubertal major depression with the Kiddie-SADS-e.

Authors:  H Orvaschel; J Puig-Antich; W Chambers; M A Tabrizi; R Johnson
Journal:  J Am Acad Child Psychiatry       Date:  1982-07

3.  Syndrome comorbidity in patients diagnosed with a DSM-III-R anxiety disorder.

Authors:  W C Sanderson; P A DiNardo; R M Rapee; D H Barlow
Journal:  J Abnorm Psychol       Date:  1990-08

4.  Quality of life in patients with panic disorder.

Authors:  P J Candilis; R Y McLean; M W Otto; G G Manfro; J J Worthington; S J Penava; P C Marzol; M H Pollack
Journal:  J Nerv Ment Dis       Date:  1999-07       Impact factor: 2.254

5.  Quality of life in early phases of panic disorder: predictive factors.

Authors:  María Carrera; Andrés Herrán; José Luís Ayuso-Mateos; Deirdre Sierra-Biddle; Maria Luz Ramírez; Ana Ayestarán; Fernando Hoyuela; Beatriz Rodríguez-Cabo; José Luís Vázquez-Barquero
Journal:  J Affect Disord       Date:  2006-06-09       Impact factor: 4.839

6.  Sertraline in generalized anxiety disorder: efficacy in treating the psychic and somatic anxiety factors.

Authors:  A A Dahl; A Ravindran; C Allgulander; S P Kutcher; C Austin; T Burt
Journal:  Acta Psychiatr Scand       Date:  2005-06       Impact factor: 6.392

Review 7.  Anxiety disorders in children and adolescents: a review of the past 10 years.

Authors:  G A Bernstein; C M Borchardt; A R Perwien
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1996-09       Impact factor: 8.829

Review 8.  Pharmacologic management of anxiety disorders in children and adolescents.

Authors:  Thomas P Williams; Bruce D Miller
Journal:  Curr Opin Pediatr       Date:  2003-10       Impact factor: 2.856

9.  Quality of life in children with psychiatric disorders: self-, parent, and clinician report.

Authors:  Dennis Bastiaansen; Hans M Koot; Robert F Ferdinand; Frank C Verhulst
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2004-02       Impact factor: 8.829

10.  Prevalence and comorbidity of DSM-III-R diagnoses in a birth cohort of 15 year olds.

Authors:  D M Fergusson; L J Horwood; M T Lynskey
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1993-11       Impact factor: 8.829

View more
  1 in total

1.  The anxiolytic-like effects of puerarin are associated with the changes of monoaminergic neurotransmitters and biosynthesis of allopregnanolone in the brain.

Authors:  Zhi-Kun Qiu; De-Sheng Zhong; Jia-Li He; Xu Liu; Ji-Sheng Chen; Hong Nie
Journal:  Metab Brain Dis       Date:  2017-11-03       Impact factor: 3.584

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.